Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Voyer, T.E.
Right arrow Articles by Haller, D.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Voyer, T.E.
Right arrow Articles by Haller, D.G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 15 (August), 2003: 2912-2919
© 2003 American Society for Clinical Oncology

Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089

T.E. Le Voyer, E.R. Sigurdson, A.L. Hanlon, R.J. Mayer, J.S. Macdonald, P.J. Catalano, D.G. Haller

From the Fox Chase Cancer Center, Philadelphia, PA; Cancer and Leukemia Group B, Chicago, IL; Southwest Oncology Group, San Antonio, TX; and Eastern Cooperative Oncology Group, Philadelphia, PA.

Address reprint requests to Elin R. Sigurdson, MD, Fox Chase Cancer Center; 7701 Burholme Ave, Philadelphia, PA 19111; email: e_sigurdson{at}fccc.edu.

Purpose: To determine the relationship, in patients with adenocarcinoma of the colon, between survival and the number of lymph nodes analyzed from surgical specimens.

Patients and Methods: Intergroup Trial INT-0089 is a mature trial of adjuvant chemotherapy for high-risk patients with stage II and stage III colon cancer. We performed a secondary analysis of this group with overall survival (OS) as the main end point. Cause-specific survival (CSS) and disease-free survival were secondary end points. Rates for these outcome measures were estimated using Kaplan-Meier methodology. Log-rank test was used to compare overall curves, and Cox proportional hazards regression was used to multivariately assess predictors of outcome.

Results: The median number of lymph nodes removed at colectomy was 11 (range, one to 87). Of the 3,411 assessable patients, 648 had no evidence of lymph node metastasis. Multivariate analyses were performed on the node-positive and node-negative groups separately to ascertain the effect of lymph node removal. Survival decreased with increasing number of lymph node involvement (P = .0001 for all three survival end points). After controlling for the number of nodes involved, survival increased as more nodes were analyzed (P = .0001 for all three end points). Even when no nodes were involved, OS and CSS improved as more lymph nodes were analyzed (P = .0005 and P = .007, respectively).

Conclusion: The number of lymph nodes analyzed for staging colon cancers is, itself, a prognostic variable on outcome. The impact of this variable is such that it may be an important variable to include in evaluating future trials.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. Ogino, K. Nosho, N. Irahara, J. A. Meyerhardt, Y. Baba, K. Shima, J. N. Glickman, C. R. Ferrone, M. Mino-Kenudson, N. Tanaka, et al.
Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
Clin. Cancer Res., October 15, 2009; 15(20): 6412 - 6420.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
S. S. Kukreja, E. Esteban-Agusti, J. M. Velasco, and T. J. Hieken
Increased Lymph Node Evaluation With Colorectal Cancer Resection: Does It Improve Detection of Stage III Disease?
Arch Surg, July 1, 2009; 144(7): 612 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
F. F. Attiyeh
Is Laparoscopic Colectomy a Good Operation for Colon Cancer?
Arch Surg, March 1, 2009; 144(3): 290 - 291.
[Full Text] [PDF]

Home page
 JAMAHome page
S. A. Waldman, T. Hyslop, S. Schulz, A. Barkun, K. Nielsen, J. Haaf, C. Bonaccorso, Y. Li, and D. S. Weinberg
Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer
JAMA, February 18, 2009; 301(7): 745 - 752.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
L H Iversen, S Laurberg, R Hagemann-Madsen, and H Dybdahl
Increased lymph node harvest from colorectal cancer resections using GEWF solution: a randomised study
J. Clin. Pathol., November 1, 2008; 61(11): 1203 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K. Y. Bilimoria, D. J. Bentrem, A. K. Stewart, M. S. Talamonti, D. P. Winchester, T. R. Russell, and C. Y. Ko
Lymph Node Evaluation as a Colon Cancer Quality Measure: A National Hospital Report Card
J Natl Cancer Inst, September 17, 2008; 100(18): 1310 - 1317.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. E. Desch, K. K. McNiff, E. C. Schneider, D. Schrag, J. McClure, E. Lepisto, M. S. Donaldson, K. L. Kahn, J. C. Weeks, C. Y. Ko, et al.
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures
J. Clin. Oncol., July 20, 2008; 26(21): 3631 - 3637.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
T. Grote, A. H. Hughes, C. C. Rimmer, D. A. Less, A. P. Abernethy, and Multidisciplinary Gastrointestinal Tumor Board, De
Targeting Lymph Node Retrieval and Assessment in Stage II Colon Cancer: A Quality Outcome Community-Based Cancer Center Study
J. Oncol. Pract, March 1, 2008; 4(2): 55 - 58.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. A. Hill, W. L. Furman, C. A. Billups, S. E. Riedley, A. M. Cain, B. N. Rao, C. B. Pratt, and S. L. Spunt
Colorectal Carcinoma in Childhood and Adolescence: A Clinicopathologic Review
J. Clin. Oncol., December 20, 2007; 25(36): 5808 - 5814.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. C. Compton
Optimal Pathologic Staging: Defining Stage II Disease
Clin. Cancer Res., November 15, 2007; 13(22): 6862s - 6870s.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. R. Turner, C. Li, and C. C. Compton
Newer Pathologic Assessment Techniques for Colorectal Carcinoma
Clin. Cancer Res., November 15, 2007; 13(22): 6871s - 6876s.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. L. Wong, H. Ji, B. K. Hollenbeck, A. M. Morris, O. Baser, and J. D. Birkmeyer
Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer
JAMA, November 14, 2007; 298(18): 2149 - 2154.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
E. J A Morris, N. J Maughan, D. Forman, and P. Quirke
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology
Gut, October 1, 2007; 56(10): 1419 - 1425.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Sezeur, F.P. Chatelet, Ch. Cywiner, Cl. de Labriolle-Vaylet, C. Chastang, Cl. Billotey, M. Malafosse, D. Gallot, P. Betton, F. Montravers, et al.
Pathology Underrates Colon Cancer Extranodal and Nodal Metastases; Ex vivo Radioimmunodetection Helps Staging
Clin. Cancer Res., September 15, 2007; 13(18): 5592s - 5597s.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Karlsson, B. F. Cole, K. N. Price, A. S. Coates, M. Castiglione-Gertsch, B. A. Gusterson, E. Murray, J. Lindtner, J. P. Collins, S. B. Holmberg, et al.
The Role of the Number of Uninvolved Lymph Nodes in Predicting Locoregional Recurrence in Breast Cancer
J. Clin. Oncol., May 20, 2007; 25(15): 2019 - 2026.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
B. M. Wolpin, J. A. Meyerhardt, H. J. Mamon, and R. J. Mayer
Adjuvant Treatment of Colorectal Cancer
CA Cancer J Clin, May 1, 2007; 57(3): 168 - 185.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. J. Chang, M. A. Rodriguez-Bigas, J. M. Skibber, and V. A. Moyer
Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review
J Natl Cancer Inst, March 21, 2007; 99(6): 433 - 441.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. N. Baxter
In Reply
J. Clin. Oncol., February 1, 2007; 25(4): 463 - 464.
[Full Text] [PDF]

Home page
 Ann OncolHome page
V. Lemmens, I van Lijnschoten, M. Janssen-Heijnen, H. Rutten, C. Verheij, and J-W. Coebergh
Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study
Ann. Onc., December 1, 2006; 17(12): 1803 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M De Ridder, V Vinh-Hung, Y Van Nieuwenhove, A Hoorens, A Sermeus, and G Storme
Prognostic value of the lymph node ratio in node positive colon cancer.
Gut, November 1, 2006; 55(11): 1681 - 1681.
[Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. M. Johnson, G. A. Porter, R. Ricciardi, and N. N. Baxter
Increasing Negative Lymph Node Count Is Independently Associated With Improved Long-Term Survival in Stage IIIB and IIIC Colon Cancer
J. Clin. Oncol., August 1, 2006; 24(22): 3570 - 3575.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Schulz, T. Hyslop, J. Haaf, C. Bonaccorso, K. Nielsen, M. E. Witek, R. Birbe, J. Palazzo, D. Weinberg, and S. A. Waldman
A Validated Quantitative Assay to Detect Occult Micrometastases by Reverse Transcriptase-Polymerase Chain Reaction of Guanylyl Cyclase C in Patients with Colorectal Cancer
Clin. Cancer Res., August 1, 2006; 12(15): 4545 - 4552.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C Mescoli, M Rugge, S Pucciarelli, V M Russo, G Pennelli, M Guido, and D Nitti
High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer
J. Clin. Pathol., August 1, 2006; 59(8): 870 - 874.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. G. Haller, P. J. Catalano, J. S. Macdonald, M. A. O'Rourke, M. S. Frontiera, D. V. Jackson, and R. J. Mayer
Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089
J. Clin. Oncol., December 1, 2005; 23(34): 8671 - 8678.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. C. Berger, E. R. Sigurdson, T. LeVoyer, A. Hanlon, R. J. Mayer, J. S. Macdonald, P. J. Catalano, and D. G. Haller
Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes
J. Clin. Oncol., December 1, 2005; 23(34): 8706 - 8712.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. E. Desch, A. B. Benson III, M. R. Somerfield, P. J. Flynn, C. Krause, C. L. Loprinzi, B. D. Minsky, D. G. Pfister, K. S. Virgo, N. J. Petrelli, et al.
Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
J. Clin. Oncol., November 20, 2005; 23(33): 8512 - 8519.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
J. H. Wong, D. S. Johnson, D. Hemmings, A. Hsu, T. Imai, and G. T. Tominaga
Assessing the Quality of Colorectal Cancer Staging: Documenting the Process in Improving the Staging of Node-Negative Colorectal Cancer
Arch Surg, September 1, 2005; 140(9): 881 - 887.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
K. M. Brown, A. J. Tompkins, S. Yong, G. V. Aranha, and M. Shoup
Pancreaticoduodenectomy Is Curative in the Majority of Patients With Node-Negative Ampullary Cancer
Arch Surg, June 1, 2005; 140(6): 529 - 533.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Grothey and D. J. Sargent
FOLFOX for Stage II Colon Cancer? A Commentary on the Recent FDA Approval of Oxaliplatin for Adjuvant Therapy of Stage III Colon Cancer
J. Clin. Oncol., May 20, 2005; 23(15): 3311 - 3313.
[Full Text] [PDF]

Home page
 Ann OncolHome page
V. E. P. P. Lemmens, A. H. van Halteren, M. L. G. Janssen-Heijnen, G. Vreugdenhil, O. J. Repelaer van Driel, and J. W. W. Coebergh
Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity
Ann. Onc., May 1, 2005; 16(5): 767 - 772.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Baddi and A. Benson III
Adjuvant Therapy in Stage II Colon Cancer: Current Approaches
Oncologist, May 1, 2005; 10(5): 325 - 331.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
N. N. Baxter, D. J. Virnig, D. A. Rothenberger, A. M. Morris, J. Jessurun, and B. A. Virnig
Lymph Node Evaluation in Colorectal Cancer Patients: A Population-Based Study
J Natl Cancer Inst, February 2, 2005; 97(3): 219 - 225.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
C. C. Compton and F. L. Greene
The Staging of Colorectal Cancer: 2004 and Beyond
CA Cancer J Clin, November 1, 2004; 54(6): 295 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Zaniboni and R. Labianca
Adjuvant therapy for stage II colon cancer: an elephant in the living room?
Ann. Onc., September 1, 2004; 15(9): 1310 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
N P Zauber, C Wang, P S Lee, T C Redondo, D T Bishop, and A Goel
Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival
J. Clin. Pathol., September 1, 2004; 57(9): 938 - 942.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. B. Benson III, D. Schrag, M. R. Somerfield, A. M. Cohen, A. T. Figueredo, P. J. Flynn, M. K. Krzyzanowska, J. Maroun, P. McAllister, E. Van Cutsem, et al.
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
J. Clin. Oncol., August 15, 2004; 22(16): 3408 - 3419.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. H. Lange and D. W. Lin
Does the Who and How of Surgery in Bladder Cancer Matter?
J. Clin. Oncol., July 15, 2004; 22(14): 2762 - 2764.
[Full Text] [PDF]

Home page
 JCOHome page
S. Gill, C. L. Loprinzi, D. J. Sargent, S. D. Thome, S. R. Alberts, D. G. Haller, J. Benedetti, G. Francini, L. E. Shepherd, J. Francois Seitz, et al.
Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?
J. Clin. Oncol., May 15, 2004; 22(10): 1797 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. B. Benson III and P. J. Catalano
A Rose, Is a Rose, Is a Rose...or Not
J. Clin. Oncol., May 15, 2004; 22(10): 1773 - 1775.
[Full Text] [PDF]

Home page
 JCOHome page
J. A. Ajani
Operate on My Stomach Cancer? Oh, No--Not You, or Not Yet!
J. Clin. Oncol., May 1, 2004; 22(9): 1763 - 1764.
[Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online